Research Article: A New Risk Score Model Based on Pyrogenic Signatures for the Prediction of Survival and Immune Microenvironment Features in Lung Adenocarcinoma
Introduction:
Currently, lung cancer remains the leading cause of cancer-related deaths worldwide. Lung adenocarcinoma (LUAD), as one of the two non-small cell lung cancer (NSCLC), accounts for about –% of all lung cancer cases. The latest progress in targeted therapy and molecular pathology has brought some benefits to LUAD patients. However, LUAD is prone to metastasis in the early stage. The prognosis of LUAD patients is poor, with the average -year overall survival (OS) rate less than %. Further understanding of the…
Read more